Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company
1970-01-01 08:00
Philips Slumps After Another Blow to Sleep Product Recall
Royal Philips NV suffered another setback as the US drug regulator requested additional tests on its sleep apnea
1970-01-01 08:00
Sanofi to Explore Acquisition of Cancer Drugmaker Mirati
French pharmaceutical giant Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc., according to people
1970-01-01 08:00